Inhibition of TRPM2 or RNA interference (RNAi) targeting TRPM2 reduced proliferation and increased DNA damage in breast adenocarcinoma cells, while having no significant effect on non-cancerous breast epithelial cells [65]. This evidence concerns the gene TRPM2 and breast adenocarcinoma.